|
|||||
|
|
Artifactual hypocalcaemia after intravenous administration of gadodiamide (Omniscan). |
|
| Authors: | Marc Decupere Vanessa Ooms Raymond Oyen Dirk R J Kuypers Kathleen Claes |
| Affiliation: | Department of Nephrology andRenal TransplantationUniversity HospitalsLeuvenBelgiumEmail: Kathleen.Claes@uz.kuleuven.ac.be |
| Abstract: | Sir, It has been documented that certain gadolinium-based magneticresonance contrast agents injected for enhancement of magneticresonance imaging (MRI) or for angiography in selected patients,i.e. gadodiamide (Omniscan®) and gadoversetamide (Optimark®),can cause spurious hypocalcaemia, due to interference with colorimetricassays in a dose-dependent way [14]. Three other agentsapproved for clinical use, gadopentetate |
| Keywords: | |
| 本文献已被 Oxford 等数据库收录！ | |